NGM Biopharmaceuticals Inc (NGM) Stock Falls -12.90% This Week; Should You Buy?

Friday, September 15, 2023 11:34 AM | InvestorsObserver Analysts

Mentioned in this article

NGM Biopharmaceuticals Inc (NGM) Stock Falls -12.90% This Week; Should You Buy?

NGM Biopharmaceuticals Inc (NGM) stock is lower by -91.25% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives NGM stock a score of 35 out of a possible 100.

That rank is primarily influenced by a long-term technical score of 4. NGM's rank also includes a short-term technical score of 7.

NGM has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on NGM!

See Full NGM Report

What's Happening with NGM Stock Today

NGM Biopharmaceuticals Inc (NGM) stock has gained 3.05% while the S&P 500 is lower by -0.87% as of 11:27 AM on Friday, Sep 15. NGM is higher by $0.04 from the previous closing price of $1.31 on volume of 101,156 shares. Over the past year the S&P 500 has gained 14.48% while NGM is lower by -91.25%. NGM lost -$2.08 per share in the over the last 12 months. Click Here to get the full Stock Report for NGM Biopharmaceuticals Inc stock.